Research output per year
Research output per year
Personal profile
Education/Academic qualification
Mecdical teaching Qualification I (postgraduate certificate in higher education), University of Tübingen
Apr 2014 → Apr 2016
Award Date: 6 Apr 2016
Doctor of Medicine, Development of an SSP-PCR-based method to specifically select HLA-A*0201 positive individuals for immunotherapeutic studies, Ludwig-Maximilians-Universität München
Nov 1995 → Jun 1999
Award Date: 11 Jun 2001
Bachelor of Medicine, Ludwig-Maximilians-Universität München
Sept 1992 → Jun 1999
Award Date: 11 Jun 1999
External positions
Birmingham Women's Hospital NHS Foundation Trust
1 Oct 2018 → …
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Susanne Gatz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma
Hebron, K. E., Odeniyide, P., Wei, Y., Gryder, B. E., Barr, F. G., Casey, D. L., Chen, E. Y., Crompton, B. D., Dela Cruz, F. S., Durbin, A. D., Ford, H. L., Gatz, S. A., Hatley, M. E., Henssen, A. G., Hettmer, S., Houghton, P. J., Kendall, G. C., Khan, J., Lupo, P. J. & Patel, A. G. & 20 others, , 10 Mar 2026, In: Cancers. 18, 6, 31 p., 888.Research output: Contribution to journal › Review article › peer-review
Open AccessFile2 Downloads (Pure) -
Phase I/II study of the PARP inhibitor olaparib and irinotecan in children and young adults with recurrent/refractory malignancies: Arm D of the AcSé-ESMART trial
Gatz, S. A., Berlanga, P., Le Teuff, G., Valiev, I., Leruste, A., André, N., Bluteau, D., Corradini, N., Rubino, J., Thomas, F., Nebchi, S., Karamouza, E., Petit, J., Thebaud, E., Rubio-San-Simón, A., van Eijkelenburg, N. K. A., Marshall, L. V., Raimbault, S., Canete, A. & Ducassou, S. & 20 others, , 27 Jan 2026, (E-pub ahead of print) In: Clinical Cancer Research.Research output: Contribution to journal › Article › peer-review
Open AccessFile9 Downloads (Pure) -
A dual readout embryonic zebrafish xenograft model of rhabdomyosarcoma to assess clinically relevant multi-receptor tyrosine kinase inhibitors
Wragg, J. W., Gray, E. L., Monteiro, R., Morris, J. R., Beggs, A. D., Müller, F. & Gatz, S. A., 21 May 2025, In: Frontiers in Oncology. 15, 19 p., 1547202.Research output: Contribution to journal › Article › peer-review
Open AccessFile118 Downloads (Pure) -
Arginine methylation regulates Ewing sarcoma cell viability in a EWSR1::FLI1 dependent manner and provides a therapeutic opportunity
Ward, C. M., Brockwell, C., McNee, G. S., Orton, E., Prowse, E. N. P., Gatz, S. A. & Davies, C. C., 1 Aug 2025, In: Frontiers in Oncology. 15, 14 p., 1538208.Research output: Contribution to journal › Article › peer-review
Open AccessFile165 Downloads (Pure) -
Childhood, Adolescent and Young Adult Poor-Prognosis Rhabdomyosarcoma
Wasti, A. T., Bisogno, G., Hladun, R., Defachelles, A.-S., Casanova, M., Breunis, W. B., Gatz, S. A., Schoot, R. A., Ferrari, A., Jenney, M., Alaggio, R., Davila Fajardo, R., Terwisscha van Scheltinga, S., Shipley, J., Meister, M. T., R. van Rijn, R., Anderson, J., Sparber-Sauer, M., Chisholm, J. C. & Merks, J. H. M., 23 Sept 2025, In: Cancers. 17, 19, 41 p., 3100.Research output: Contribution to journal › Review article › peer-review
Open AccessFile6 Downloads (Pure)
-
Rethinking outcomes and statistical analyses for paediatric cancer trials
Kirton, L. (Co-Investigator), Gatz, S. (Co-Investigator), Billingham, L. (Co-Investigator) & Gates, S. (Principal Investigator)
1/11/25 → 30/04/28
Project: Research
-
Treating Ewing Sarcoma with PRMT5 inhibitors - a novel opportunity with real translational potential
Davies, C. (Principal Investigator) & Gatz, S. (Co-Investigator)
1/10/25 → 30/09/28
Project: Research
-
Exploiting the radiobiological potential of protons and high-LET radiation
Mehanna, H. (Researcher), Petermann, E. (Researcher), Tennant, D. (Co-Investigator), Kokalova Wheldon, T. (Co-Investigator), Bishop, J. (Co-Investigator), Watts, C. (Researcher), Parish, J. (Researcher), Parsons, J. (Principal Investigator), Gatz, S. (Researcher), Phoenix, B. (Co-Investigator) & Beggs, A. (Co-Investigator)
1/01/25 → 31/12/29
Project: Research
-
MINT: mIBG therapy in neuroblastoma combined with talazoparib
Burke, A. (Principal Investigator), Slade, D. (Researcher) & Gatz, S. (Researcher)
1/04/24 → 31/03/28
Project: Research
-
Novel biomarkers for PARP inhibitor trials for children with cancer
Stankovic, T. (Co-Investigator), Beggs, A. (Co-Investigator) & Gatz, S. (Principal Investigator)
1/02/21 → 31/07/28
Project: Research